Senseonics Holdings, Inc. (SENS)
 NYSEAMERICAN: SENS · Real-Time Price · USD
 7.21
 -0.04 (-0.55%)
  At close: Oct 30, 2025, 4:00 PM EDT
7.32
 +0.11 (1.53%)
  After-hours: Oct 30, 2025, 7:33 PM EDT
Senseonics Holdings Revenue
Senseonics Holdings had revenue of $6.65M in the quarter ending June 30, 2025, with 36.67% growth. This brings the company's revenue in the last twelve months to $25.47M, up 5.94% year-over-year. In the year 2024, Senseonics Holdings had annual revenue of $22.47M with 0.37% growth.
Revenue (ttm) 
 $25.47M
Revenue Growth 
 +5.94%
P/S Ratio 
 9.98
Revenue / Employee 
 $217,658
Employees 
 117
Market Cap 
293.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 22.47M | 82.00K | 0.37% | 
| Dec 31, 2023 | 22.39M | 6.00M | 36.62% | 
| Dec 31, 2022 | 16.39M | 2.71M | 19.85% | 
| Dec 31, 2021 | 13.68M | 8.73M | 176.32% | 
| Dec 31, 2020 | 4.95M | -16.35M | -76.77% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| UnitedHealth Group | 435.16B | 
| Johnson & Johnson | 92.15B | 
| Merck & Co. | 63.62B | 
| AbbVie | 58.33B | 
| AstraZeneca | 56.50B | 
| Novartis AG | 56.37B | 
| Eli Lilly and Company | 53.26B | 
| Novo Nordisk | 49.11B | 
SENS News
- 8 days ago - Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time - GlobeNewsWire
- 24 days ago - Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update - GlobeNewsWire
- 2 months ago - Senseonics Holdings, Inc. (SENS) Eversense 365 Commercial Update Call (Transcript) - Seeking Alpha
- 2 months ago - Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics - Business Wire
- 2 months ago - Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365 - GlobeNewsWire
- 3 months ago - Senseonics Holdings, Inc. (SENS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Senseonics Holdings, Inc. Reports Second Quarter Financial Results - GlobeNewsWire
- 3 months ago - Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time - GlobeNewsWire